Waltham, Mass., devicemaker NeuroMetrix will debut its FDA-cleared wearable pain relief device at the 2015 International Consumer Electronics show, Jan. 6-9 in Las Vegas.

The device, which will be sold under the brand name Quell, uses noninvasive electrical stimulation of sensory nerves to spur safe and effective pain relief caused by diabetes, sciatica, fibromyalgia, degenerative knee conditions and other ailments, NeuroMetrix says. The lightweight device can be worn during daily activities and while sleeping at night. Users can also use their smartphone to track and personalize their pain therapy, according to the company.

Quell received 510(k) clearance in July for treatment of chronic pain without a prescription. The company expects Quell to be available over-the-counter in the second quarter of 2015.

NeuroMetrix also makes and markets the SENSUS pain management system using its proprietary noninvasive neurostimulation technology. — Kellen Owings